CD8A and neoplasm: Deubiquitinating and stabilizing p65 with ubiquitin-specific peptidase 12 (USP12) impair infiltration and suppressive function of M-MDSCs, thus increasing CD8+ T-cell response and decelerating tumor growth [76].